<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-11-01" modified="2019-09-18" version="178">
<accession>P05793</accession>
<accession>Q2M883</accession>
<name>ILVC_ECOLI</name>
<protein>
<recommendedName>
<fullName evidence="3 17">Ketol-acid reductoisomerase (NADP(+))</fullName>
<shortName evidence="3 17">KARI</shortName>
<ecNumber evidence="3 6 8 11 14">1.1.1.86</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="3 17">Acetohydroxy-acid isomeroreductase</fullName>
<shortName evidence="3 17">AHIR</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="3">Alpha-keto-beta-hydroxylacyl reductoisomerase</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="3 16">Ketol-acid reductoisomerase type 2</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="3 16">Ketol-acid reductoisomerase type II</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="3">ilvC</name>
<name type="ordered locus">b3774</name>
<name type="ordered locus">JW3747</name>
</gene>
<organism>
<name type="scientific">Escherichia coli (strain K12)</name>
<dbReference type="NCBI Taxonomy" id="83333"/>
<lineage>
<taxon>Bacteria</taxon>
<taxon>Proteobacteria</taxon>
<taxon>Gammaproteobacteria</taxon>
<taxon>Enterobacterales</taxon>
<taxon>Enterobacteriaceae</taxon>
<taxon>Escherichia</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="J. Biol. Chem." volume="261" first="2441" last="2450">
<title>Nucleotide sequence and in vivo expression of the ilvY and ilvC genes in Escherichia coli K12. Transcription from divergent overlapping promoters.</title>
<authorList>
<person name="Wek R.C."/>
<person name="Hatfield G.W."/>
</authorList>
<dbReference type="PubMed" id="3003115"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>INDUCTION</scope>
<source>
<strain>K12</strain>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="Science" volume="257" first="771" last="778">
<title>Analysis of the Escherichia coli genome: DNA sequence of the region from 84.5 to 86.5 minutes.</title>
<authorList>
<person name="Daniels D.L."/>
<person name="Plunkett G. III"/>
<person name="Burland V.D."/>
<person name="Blattner F.R."/>
</authorList>
<dbReference type="PubMed" id="1379743"/>
<dbReference type="DOI" id="10.1126/science.1379743"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / MG1655 / ATCC 47076</strain>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Science" volume="277" first="1453" last="1462">
<title>The complete genome sequence of Escherichia coli K-12.</title>
<authorList>
<person name="Blattner F.R."/>
<person name="Plunkett G. III"/>
<person name="Bloch C.A."/>
<person name="Perna N.T."/>
<person name="Burland V."/>
<person name="Riley M."/>
<person name="Collado-Vides J."/>
<person name="Glasner J.D."/>
<person name="Rode C.K."/>
<person name="Mayhew G.F."/>
<person name="Gregor J."/>
<person name="Davis N.W."/>
<person name="Kirkpatrick H.A."/>
<person name="Goeden M.A."/>
<person name="Rose D.J."/>
<person name="Mau B."/>
<person name="Shao Y."/>
</authorList>
<dbReference type="PubMed" id="9278503"/>
<dbReference type="DOI" id="10.1126/science.277.5331.1453"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / MG1655 / ATCC 47076</strain>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Mol. Syst. Biol." volume="2" first="E1" last="E5">
<title>Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110.</title>
<authorList>
<person name="Hayashi K."/>
<person name="Morooka N."/>
<person name="Yamamoto Y."/>
<person name="Fujita K."/>
<person name="Isono K."/>
<person name="Choi S."/>
<person name="Ohtsubo E."/>
<person name="Baba T."/>
<person name="Wanner B.L."/>
<person name="Mori H."/>
<person name="Horiuchi T."/>
</authorList>
<dbReference type="PubMed" id="16738553"/>
<dbReference type="DOI" id="10.1038/msb4100049"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1997" name="Electrophoresis" volume="18" first="1259" last="1313">
<title>Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12.</title>
<authorList>
<person name="Link A.J."/>
<person name="Robison K."/>
<person name="Church G.M."/>
</authorList>
<dbReference type="PubMed" id="9298646"/>
<dbReference type="DOI" id="10.1002/elps.1150180807"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-13</scope>
<source>
<strain>K12 / EMG2</strain>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1988" name="J. Mol. Biol." volume="203" first="643" last="663">
<title>Transcriptional activation at adjacent operators in the divergent-overlapping ilvY and ilvC promoters of Escherichia coli.</title>
<authorList>
<person name="Wek R.C."/>
<person name="Hatfield G.W."/>
</authorList>
<dbReference type="PubMed" id="3062177"/>
<dbReference type="DOI" id="10.1016/0022-2836(88)90199-4"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1989" name="Biochemistry" volume="28" first="486" last="493">
<title>Mechanism of ketol acid reductoisomerase--steady-state analysis and metal ion requirement.</title>
<authorList>
<person name="Chunduru S.K."/>
<person name="Mrachko G.T."/>
<person name="Calvo K.C."/>
</authorList>
<dbReference type="PubMed" id="2653423"/>
<dbReference type="DOI" id="10.1021/bi00428a012"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>COFACTOR</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PATHWAY</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1990" name="Biochemistry" volume="29" first="2824" last="2830">
<title>Oxalyl hydroxamates as reaction-intermediate analogues for ketol-acid reductoisomerase.</title>
<authorList>
<person name="Aulabaugh A."/>
<person name="Schloss J.V."/>
</authorList>
<dbReference type="PubMed" id="2189496"/>
<dbReference type="DOI" id="10.1021/bi00463a027"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1997" name="Arch. Biochem. Biophys." volume="338" first="83" last="89">
<title>Reversal of the nucleotide specificity of ketol acid reductoisomerase by site-directed mutagenesis identifies the NADPH binding site.</title>
<authorList>
<person name="Rane M.J."/>
<person name="Calvo K.C."/>
</authorList>
<dbReference type="PubMed" id="9015391"/>
<dbReference type="DOI" id="10.1006/abbi.1996.9802"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>MUTAGENESIS OF ARG-68; LYS-69; LYS-75 AND ARG-76</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="FEBS J." volume="272" first="593" last="602">
<title>Probing the mechanism of the bifunctional enzyme ketol-acid reductoisomerase by site-directed mutagenesis of the active site.</title>
<authorList>
<person name="Tyagi R."/>
<person name="Lee Y.T."/>
<person name="Guddat L.W."/>
<person name="Duggleby R.G."/>
</authorList>
<dbReference type="PubMed" id="15654896"/>
<dbReference type="DOI" id="10.1111/j.1742-4658.2004.04506.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>COFACTOR</scope>
<scope>MUTAGENESIS OF HIS-132; LYS-155; GLU-213; ASP-217; GLU-221; GLU-389; GLU-393 AND SER-414</scope>
<scope>SUBSTRATE SPECIFICITY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2011" name="Metab. Eng." volume="13" first="345" last="352">
<title>Engineered ketol-acid reductoisomerase and alcohol dehydrogenase enable anaerobic 2-methylpropan-1-ol production at theoretical yield in Escherichia coli.</title>
<authorList>
<person name="Bastian S."/>
<person name="Liu X."/>
<person name="Meyerowitz J.T."/>
<person name="Snow C.D."/>
<person name="Chen M.M."/>
<person name="Arnold F.H."/>
</authorList>
<dbReference type="PubMed" id="21515217"/>
<dbReference type="DOI" id="10.1016/j.ymben.2011.02.004"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>MUTAGENESIS OF ALA-71; ARG-76; SER-78 AND GLN-110</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Protein Sci." volume="14" first="3089" last="3100">
<title>The crystal structure of a bacterial class II ketol-acid reductoisomerase: domain conservation and evolution.</title>
<authorList>
<person name="Tyagi R."/>
<person name="Duquerroy S."/>
<person name="Navaza J."/>
<person name="Guddat L.W."/>
<person name="Duggleby R.G."/>
</authorList>
<dbReference type="PubMed" id="16322583"/>
<dbReference type="DOI" id="10.1110/ps.051791305"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS)</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2012" name="J. Mol. Biol." volume="424" first="168" last="179">
<title>Bacterial and plant ketol-acid reductoisomerases have different mechanisms of induced fit during the catalytic cycle.</title>
<authorList>
<person name="Wong S.H."/>
<person name="Lonhienne T.G."/>
<person name="Winzor D.J."/>
<person name="Schenk G."/>
<person name="Guddat L.W."/>
</authorList>
<dbReference type="PubMed" id="23036858"/>
<dbReference type="DOI" id="10.1016/j.jmb.2012.09.018"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) IN COMPLEX WITH MAGNESIUM AND NADP</scope>
<scope>COFACTOR</scope>
<scope>SUBUNIT</scope>
</reference>
<comment type="function">
<text evidence="6 8 11 14">Involved in the biosynthesis of branched-chain amino acids (BCAA). Catalyzes an alkyl-migration followed by a ketol-acid reduction of (S)-2-acetolactate (S2AL) to yield (R)-2,3-dihydroxy-isovalerate. In the isomerase reaction, S2AL is rearranged via a Mg-dependent methyl migration to produce 3-hydroxy-3-methyl-2-ketobutyrate (HMKB). In the reductase reaction, this 2-ketoacid undergoes a metal-dependent reduction by NADPH to yield (R)-2,3-dihydroxy-isovalerate. Also able to use 2-ketopantoate, 2-ketoisovalerate, 2-ketovalerate, 2-ketobutyrate, 3-hydroxypyruvate, 3-hydroxy-2-ketobutyrate and pyruvate (PubMed:15654896).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="3 6 8 11 14">
<text>(2R)-2,3-dihydroxy-3-methylbutanoate + NADP(+) = (2S)-2-acetolactate + H(+) + NADPH</text>
<dbReference type="Rhea" id="RHEA:22068"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:49072"/>
<dbReference type="ChEBI" id="CHEBI:57783"/>
<dbReference type="ChEBI" id="CHEBI:58349"/>
<dbReference type="ChEBI" id="CHEBI:58476"/>
<dbReference type="EC" id="1.1.1.86"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="3">
<text>(2R,3R)-2,3-dihydroxy-3-methylpentanoate + NADP(+) = (S)-2-ethyl-2-hydroxy-3-oxobutanoate + H(+) + NADPH</text>
<dbReference type="Rhea" id="RHEA:13493"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:49256"/>
<dbReference type="ChEBI" id="CHEBI:49258"/>
<dbReference type="ChEBI" id="CHEBI:57783"/>
<dbReference type="ChEBI" id="CHEBI:58349"/>
<dbReference type="EC" id="1.1.1.86"/>
</reaction>
</comment>
<comment type="cofactor">
<cofactor evidence="3 6 10 11">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
<text evidence="3 10 11">Binds 2 magnesium ions per subunit.</text>
</comment>
<comment type="activity regulation">
<text evidence="9">Inhibited by N-hydroxy-N-isopropyloxamate (IpOHA).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="8">0.04 mM for NADPH</KM>
<KM evidence="14">0.042 mM for NADP</KM>
<KM evidence="14">0.073 mM for NADPH</KM>
<KM evidence="6">0.17 mM for 2-ketopantoate (at pH 8 and 37 degrees Celsius)</KM>
<KM evidence="14">0.206 mM for NADH</KM>
<KM evidence="6">0.21 mM for 3-hydroxy-2-ketobutyrate (at pH 8 and 37 degrees Celsius)</KM>
<KM evidence="6">0.25 mM for 2-acetolactate (at pH 8 and 37 degrees Celsius)</KM>
<KM evidence="6">0.27 mM for 3-hydroxy-3-methyl-2-ketobutyrate (at pH 8 and 37 degrees Celsius)</KM>
<KM evidence="11">0.42 mM for magnesium (with S2AL and NADPH as substrates)</KM>
<KM evidence="8">1.08 mM for NADH</KM>
<KM evidence="11">1.54 mM for pyruvate (at pH 8 and 37 degrees Celsius)</KM>
<KM evidence="11">2.96 mM for 3-hydroxypyruvate (at pH 8 and 37 degrees Celsius)</KM>
<KM evidence="11">3.15 mM for 2-ketovalerate (at pH 8 and 37 degrees Celsius)</KM>
<KM evidence="11">4.56 mM for 2-ketobutyrate (at pH 8 and 37 degrees Celsius)</KM>
<KM evidence="11">6.91 mM for 2-ketoisovalerate (at pH 8 and 37 degrees Celsius)</KM>
<Vmax evidence="6">5.421 umol/min/mg enzyme with 3-hydroxypyruvate as substrate (at pH 8 and 37 degrees Celsius)</Vmax>
<Vmax evidence="6">3.541 umol/min/mg enzyme with 3-hydroxy-3-methyl-2-ketobutyrate as substrate (at pH 8 and 37 degrees Celsius)</Vmax>
<Vmax evidence="6">2.25 umol/min/mg enzyme with 2-acetolactate as substrate (at pH 8 and 37 degrees Celsius)</Vmax>
<Vmax evidence="6">0.599 umol/min/mg enzyme with 3-hydroxy-2-ketobutyrate as substrate (at pH 8 and 37 degrees Celsius)</Vmax>
<Vmax evidence="6">0.196 umol/min/mg enzyme with 2-ketopantoate as substrate (at pH 8 and 37 degrees Celsius)</Vmax>
<Vmax evidence="6">0.184 umol/min/mg enzyme with 2-ketoisovalerate as substrate (at pH 8 and 37 degrees Celsius)</Vmax>
<Vmax evidence="6">0.168 umol/min/mg enzyme with 2-ketobutyrate as substrate (at pH 8 and 37 degrees Celsius)</Vmax>
<Vmax evidence="6">0.05 umol/min/mg enzyme with 2-ketovalerate as substrate (at pH 8 and 37 degrees Celsius)</Vmax>
<Vmax evidence="6">0.021 umol/min/mg enzyme with pyruvate as substrate (at pH 8 and 37 degrees Celsius)</Vmax>
<text evidence="6 8 14">Kcat is 7.2 min(-1) for reductoisomerase activity with NADPH as substrate (PubMed:9015391). Kcat is 3.1 min(-1) for reductoisomerase activity with NADPH as substrate (PubMed:9015391). Kcat is 0.11 min(-1) for reductoisomerase activity with NADH as substrate (PubMed:9015391). Kcat is 5.376 sec(-1) for reductoisomerase activity with 3-hydroxypyruvate as substrate (at pH 8 and 37 degrees Celsius) (PubMed:15654896). Kcat is 3.6 sec(-1) for reductoisomerase activity with NADPH as substrate (PubMed:21515217). Kcat is 3.511 sec(-1) for reductoisomerase activity with 3-hydroxy-3-methyl-2-ketobutyrate as substrate (at pH 8 and 37 degrees Celsius) (PubMed:15654896). Kcat is 2.231 sec(-1) for reductoisomerase activity with 2-acetolactate as substrate (at pH 8 and 37 degrees Celsius) (PubMed:15654896). Kcat is 0.594 sec(-1) for reductoisomerase activity with 3-hydroxy-2-ketobutyrate as substrate (at pH 8 and 37 degrees Celsius) (PubMed:15654896). Kcat is 0.3 sec(-1) for reductoisomerase activity with NADH as substrate (PubMed:21515217). Kcat is 0.194 sec(-1) for reductoisomerase activity with 2-ketopantoate as substrate (at pH 8 and 37 degrees Celsius) (PubMed:15654896). Kcat is 0.182 sec(-1) for reductoisomerase activity with 2-ketoisovalerate as substrate (at pH 8 and 37 degrees Celsius) (PubMed:15654896). Kcat is 0.167 sec(-1) for reductoisomerase activity with 2-ketobutyrate as substrate (at pH 8 and 37 degrees Celsius) (PubMed:15654896). Kcat is 0.05 sec(-1) for reductoisomerase activity with 2-ketovalerate as substrate (at pH 8 and 37 degrees Celsius) (PubMed:15654896). Kcat is 0.021 sec(-1) for reductoisomerase activity with pyruvate as substrate (at pH 8 and 37 degrees Celsius) (PubMed:15654896).</text>
</kinetics>
</comment>
<comment type="pathway" evidence="3 20">
<text>Amino-acid biosynthesis; L-isoleucine biosynthesis; L-isoleucine from 2-oxobutanoate: step 2/4.</text>
</comment>
<comment type="pathway" evidence="3 20">
<text>Amino-acid biosynthesis; L-valine biosynthesis; L-valine from pyruvate: step 2/4.</text>
</comment>
<comment type="subunit">
<text evidence="7 10">Homotetramer.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="20">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="induction">
<text evidence="12 13">In the presence of acetohydroxybutyrate and acetolactate and by the activator IlvY.</text>
</comment>
<comment type="similarity">
<text evidence="3">Belongs to the ketol-acid reductoisomerase family.</text>
</comment>
<dbReference type="EC" id="1.1.1.86" evidence="3 6 8 11 14"/>
<dbReference type="EMBL" id="M11689">
<property type="protein sequence ID" value="AAA24029.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M87049">
<property type="protein sequence ID" value="AAA67577.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U00096">
<property type="protein sequence ID" value="AAC76779.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP009048">
<property type="protein sequence ID" value="BAE77523.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="PIR" id="A65181">
<property type="entry name" value="ISECKR"/>
</dbReference>
<dbReference type="RefSeq" id="NP_418222.1">
<property type="nucleotide sequence ID" value="NC_000913.3"/>
</dbReference>
<dbReference type="RefSeq" id="WP_000024939.1">
<property type="nucleotide sequence ID" value="NZ_SSZK01000025.1"/>
</dbReference>
<dbReference type="PDB" id="1YRL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B/C/D=1-491"/>
</dbReference>
<dbReference type="PDB" id="3ULK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=1-491"/>
</dbReference>
<dbReference type="PDBsum" id="1YRL"/>
<dbReference type="PDBsum" id="3ULK"/>
<dbReference type="SMR" id="P05793"/>
<dbReference type="BioGrid" id="4263331">
<property type="interactions" value="21"/>
</dbReference>
<dbReference type="BioGrid" id="852586">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="IntAct" id="P05793">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="STRING" id="511145.b3774"/>
<dbReference type="BindingDB" id="P05793"/>
<dbReference type="ChEMBL" id="CHEMBL2366462"/>
<dbReference type="SWISS-2DPAGE" id="P05793"/>
<dbReference type="EPD" id="P05793"/>
<dbReference type="jPOST" id="P05793"/>
<dbReference type="PaxDb" id="P05793"/>
<dbReference type="PRIDE" id="P05793"/>
<dbReference type="EnsemblBacteria" id="AAC76779">
<property type="protein sequence ID" value="AAC76779"/>
<property type="gene ID" value="b3774"/>
</dbReference>
<dbReference type="EnsemblBacteria" id="BAE77523">
<property type="protein sequence ID" value="BAE77523"/>
<property type="gene ID" value="BAE77523"/>
</dbReference>
<dbReference type="GeneID" id="948286"/>
<dbReference type="KEGG" id="ecj:JW3747"/>
<dbReference type="KEGG" id="eco:b3774"/>
<dbReference type="PATRIC" id="fig|511145.12.peg.3891"/>
<dbReference type="EchoBASE" id="EB0490"/>
<dbReference type="EcoGene" id="EG10495">
<property type="gene designation" value="ilvC"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4105C6M">
<property type="taxonomic scope" value="Bacteria"/>
</dbReference>
<dbReference type="eggNOG" id="COG0059">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000286135"/>
<dbReference type="InParanoid" id="P05793"/>
<dbReference type="KO" id="K00053"/>
<dbReference type="PhylomeDB" id="P05793"/>
<dbReference type="BioCyc" id="EcoCyc:KETOLREDUCTOISOM-MONOMER"/>
<dbReference type="BioCyc" id="ECOL316407:JW3747-MONOMER"/>
<dbReference type="BioCyc" id="MetaCyc:KETOLREDUCTOISOM-MONOMER"/>
<dbReference type="BRENDA" id="1.1.1.86">
<property type="organism ID" value="2026"/>
</dbReference>
<dbReference type="UniPathway" id="UPA00047">
<property type="reaction ID" value="UER00056"/>
</dbReference>
<dbReference type="UniPathway" id="UPA00049">
<property type="reaction ID" value="UER00060"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P05793"/>
<dbReference type="PRO" id="PR:P05793"/>
<dbReference type="Proteomes" id="UP000000318">
<property type="component" value="Chromosome"/>
</dbReference>
<dbReference type="Proteomes" id="UP000000625">
<property type="component" value="Chromosome"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="GO" id="GO:0004455">
<property type="term" value="F:ketol-acid reductoisomerase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050661">
<property type="term" value="F:NADP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009097">
<property type="term" value="P:isoleucine biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="GO" id="GO:0051289">
<property type="term" value="P:protein homotetramerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="GO" id="GO:0009099">
<property type="term" value="P:valine biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.1040.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="HAMAP" id="MF_00435">
<property type="entry name" value="IlvC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR008927">
<property type="entry name" value="6-PGluconate_DH-like_C_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013328">
<property type="entry name" value="6PGD_dom2"/>
</dbReference>
<dbReference type="InterPro" id="IPR013023">
<property type="entry name" value="KARI"/>
</dbReference>
<dbReference type="InterPro" id="IPR000506">
<property type="entry name" value="KARI_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR013116">
<property type="entry name" value="KARI_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR036291">
<property type="entry name" value="NAD(P)-bd_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR21371">
<property type="entry name" value="PTHR21371"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01450">
<property type="entry name" value="IlvC"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF07991">
<property type="entry name" value="IlvN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48179">
<property type="entry name" value="SSF48179"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51735">
<property type="entry name" value="SSF51735"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00465">
<property type="entry name" value="ilvC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51851">
<property type="entry name" value="KARI_C"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS51850">
<property type="entry name" value="KARI_N"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0028">Amino-acid biosynthesis</keyword>
<keyword id="KW-0100">Branched-chain amino acid biosynthesis</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0521">NADP</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<feature type="initiator methionine" description="Removed" evidence="15">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Ketol-acid reductoisomerase (NADP(+))" id="PRO_0000151309">
<location>
<begin position="2"/>
<end position="491"/>
</location>
</feature>
<feature type="domain" description="KARI N-terminal Rossmann" evidence="4 19">
<location>
<begin position="15"/>
<end position="208"/>
</location>
</feature>
<feature type="domain" description="KARI C-terminal knotted 1" evidence="5 19">
<location>
<begin position="209"/>
<end position="344"/>
</location>
</feature>
<feature type="domain" description="KARI C-terminal knotted 2" evidence="5 19">
<location>
<begin position="345"/>
<end position="484"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NADP" evidence="3 10">
<location>
<begin position="45"/>
<end position="48"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NADP" evidence="3 10">
<location>
<begin position="108"/>
<end position="110"/>
</location>
</feature>
<feature type="active site" evidence="3">
<location>
<position position="132"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 1" evidence="3 10">
<location>
<position position="217"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2" evidence="3 10">
<location>
<position position="217"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 1" evidence="3">
<location>
<position position="221"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2" evidence="3 10">
<location>
<position position="389"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2" evidence="3 10">
<location>
<position position="393"/>
</location>
</feature>
<feature type="binding site" description="NADP" evidence="3 21">
<location>
<position position="68"/>
</location>
</feature>
<feature type="binding site" description="NADP" evidence="3 10 21">
<location>
<position position="76"/>
</location>
</feature>
<feature type="binding site" description="NADP" evidence="3 10">
<location>
<position position="78"/>
</location>
</feature>
<feature type="binding site" description="NADP; via amide nitrogen" evidence="3">
<location>
<position position="158"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="3">
<location>
<position position="414"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inversion of cofactor specificity from NADPH to NADH; when associated with L-69, V-75 and D-76." evidence="14">
<original>R</original>
<variation>D</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="mutagenesis site" description="18-fold decrease of the catalytic efficiency and 3-fold decrease of the affinity for NADPH." evidence="14">
<original>R</original>
<variation>Q</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not significantly alter the affinity for NADPH. Slight increase of the catalytic efficiency. Inversion of cofactor specificity from NADPH to NADH; when associated with D-68, V-75 and D-76." evidence="14">
<original>K</original>
<variation>L</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="mutagenesis site" description="7- and 2.5-fold increase of the reductoisomerase activity with NADH and NADPH, respectively." evidence="8">
<original>A</original>
<variation>S</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="mutagenesis site" description="13-fold decrease of the catalytic efficiency and 3-fold increase of the affinity for NADPH." evidence="14">
<original>K</original>
<variation>Q</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inversion of cofactor specificity from NADPH to NADH; when associated with D-68, L-69 and D-76." evidence="14">
<original>K</original>
<variation>V</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="mutagenesis site" description="3-fold increase of the reductoisomerase activity with NADH and slight decrease of the reductoisomerase activity with NADPH." evidence="8">
<original>R</original>
<variation>D</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strong increase of catalytic efficiency and 2.5-fold increase of the affinity for NADH. 4-fold decrease of the catalytic efficiency and strong decrease of the affinity for NADPH. Inversion of cofactor specificity from NADPH to NADH; when associated with D-68, L-69 and V-75." evidence="14">
<original>R</original>
<variation>D</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="mutagenesis site" description="20-fold decrease of the catalytic efficiency and 5-fold decrease of the affinity for NADPH." evidence="14">
<original>R</original>
<variation>Q</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="mutagenesis site" description="12-fold increase of the reductoisomerase activity with NADH and slight decrease of the reductoisomerase activity with NADPH." evidence="8">
<original>S</original>
<variation>D</variation>
<location>
<position position="78"/>
</location>
</feature>
<feature type="mutagenesis site" description="12- and 2-fold increase of the reductoisomerase activity with NADH and NADPH, respectively." evidence="8">
<original>Q</original>
<variation>V</variation>
<variation>A</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of reductoisomerase activity." evidence="6">
<original>H</original>
<variation>K</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of reductoisomerase activity. The reductase activity with 3-hydroxypyruvate and HMKB is nearly normal, and the isomerase activity decreases 24-fold." evidence="6">
<original>H</original>
<variation>Q</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of reductoisomerase activity." evidence="6">
<original>K</original>
<variation>E</variation>
<variation>Q</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of reductoisomerase activity. The reductase activity with 3-hydroxypyruvate and HMKB is nearly normal, and the isomerase activity decreases 40-fold." evidence="6">
<original>K</original>
<variation>R</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of reductoisomerase activity. 1.5-fold decrease of the reductase activity with 3-hydroxypyruvate and the isomerase activity decreases 48-fold." evidence="6">
<original>E</original>
<variation>D</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of reductoisomerase activity." evidence="6">
<original>D</original>
<variation>E</variation>
<variation>N</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of reductoisomerase activity." evidence="6">
<original>E</original>
<variation>D</variation>
<variation>Q</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of reductoisomerase activity. 1.5-fold decrease of the reductase activity with 3-hydroxypyruvate and the isomerase activity decreases 4-fold." evidence="6">
<original>E</original>
<variation>D</variation>
<location>
<position position="389"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of reductoisomerase activity." evidence="6">
<original>E</original>
<variation>Q</variation>
<location>
<position position="389"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of reductoisomerase activity. The reductase activity with HMKB is nearly normal." evidence="6">
<original>E</original>
<variation>D</variation>
<location>
<position position="393"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of reductoisomerase activity. The isomerase activity decreases 15-fold." evidence="6">
<original>S</original>
<variation>A</variation>
<location>
<position position="414"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of reductoisomerase activity. The isomerase activity decreases 24-fold." evidence="6">
<original>S</original>
<variation>T</variation>
<location>
<position position="414"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA24029." ref="1" evidence="18">
<original>E</original>
<variation>K</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="5"/>
<end position="7"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="10"/>
<end position="17"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="20"/>
<end position="22"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="25"/>
<end position="28"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="29"/>
<end position="32"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="33"/>
<end position="35"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="38"/>
<end position="44"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="47"/>
<end position="58"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="62"/>
<end position="67"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="69"/>
<end position="73"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="77"/>
<end position="84"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="88"/>
<end position="91"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="92"/>
<end position="95"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="96"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="100"/>
<end position="104"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="108"/>
<end position="110"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="111"/>
<end position="118"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="119"/>
<end position="121"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="127"/>
<end position="132"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="134"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="147"/>
<end position="156"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="158"/>
<end position="166"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="173"/>
<end position="177"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="179"/>
<end position="181"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="187"/>
<end position="197"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="200"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="205"/>
<end position="207"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="210"/>
<end position="222"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="223"/>
<end position="226"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="227"/>
<end position="242"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="247"/>
<end position="275"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="279"/>
<end position="309"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="311"/>
<end position="321"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="322"/>
<end position="324"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="325"/>
<end position="336"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="338"/>
<end position="341"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="351"/>
<end position="356"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="359"/>
<end position="377"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="378"/>
<end position="380"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="383"/>
<end position="388"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="391"/>
<end position="393"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="394"/>
<end position="412"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="415"/>
<end position="431"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="433"/>
<end position="437"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="443"/>
<end position="446"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="455"/>
<end position="466"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="469"/>
<end position="487"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1YRL"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3ULK"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="HAMAP-Rule" id="MF_00435"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01197"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01198"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15654896"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16322583"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21515217"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2189496"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23036858"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2653423"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3003115"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3062177"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9015391"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9298646"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16322583"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2653423"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000305"/>
<evidence key="19" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="16322583"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="2653423"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="9015391"/>
</source>
</evidence>
<sequence length="491" mass="54069" checksum="9CA34BA61C9AEBBA" modified="2007-01-23" version="4">MANYFNTLNLRQQLAQLGKCRFMGRDEFADGASYLQGKKVVIVGCGAQGLNQGLNMRDSGLDISYALRKEAIAEKRASWRKATENGFKVGTYEELIPQADLVINLTPDKQHSDVVRTVQPLMKDGAALGYSHGFNIVEVGEQIRKDITVVMVAPKCPGTEVREEYKRGFGVPTLIAVHPENDPKGEGMAIAKAWAAATGGHRAGVLESSFVAEVKSDLMGEQTILCGMLQAGSLLCFDKLVEEGTDPAYAEKLIQFGWETITEALKQGGITLMMDRLSNPAKLRAYALSEQLKEIMAPLFQKHMDDIISGEFSSGMMADWANDDKKLLTWREETGKTAFETAPQYEGKIGEQEYFDKGVLMIAMVKAGVELAFETMVDSGIIEESAYYESLHELPLIANTIARKRLYEMNVVISDTAEYGNYLFSYACVPLLKPFMAELQPGDLGKAIPEGAVDNGQLRDVNEAIRSHAIEQVGKKLRGYMTDMKRIAVAG</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>